Dyne Therapeutics (DYN) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$23.86

+0.21 (+0.89%)

(As of 05:21 PM ET)

Source

Source	Headline
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Sees Large Increase in Short Interest americanbankingnews.com - April 16 at 5:10 AM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Short Interest Up 18.5% in March marketbeat.com - April 14 at 11:39 AM
	Stifel Nicolaus Keeps Their Hold Rating on Ionis Pharmaceuticals (IONS) markets.businessinsider.com - April 8 at 1:46 PM
	Dyne Therapeutics (NASDAQ:DYN) Trading Down 3% marketbeat.com - April 4 at 3:26 PM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Sold by Assenagon Asset Management S.A. marketbeat.com - April 2 at 4:38 AM
	Dyne Therapeutics (NASDAQ:DYN) Shares Up 9.9% marketbeat.com - March 27 at 4:44 PM
	Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer globenewswire.com - March 27 at 4:05 PM
	Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium globenewswire.com - March 27 at 8:30 AM
	Analysts Are Bullish on Top Healthcare Stocks: Dyne Therapeutics (DYN), Addus Homecare (ADUS) markets.businessinsider.com - March 26 at 11:06 PM
	Oppenheimer Reiterates "Outperform" Rating for Dyne Therapeutics (NASDAQ:DYN) marketbeat.com - March 26 at 10:46 AM
	Dyne announces CEO transition, former Biogen exec tapped for top spot bizjournals.com - March 25 at 6:44 PM
	Dyne Therapeutics Shares Drop 14% on CEO Joshua Brumm Departure marketwatch.com - March 25 at 4:19 PM
	Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down to $28.24 marketbeat.com - March 25 at 11:55 AM
	Dyne Therapeutics, Inc.: Dyne Therapeutics Announces CEO Transition finanznachrichten.de - March 25 at 9:25 AM
	Dyne Therapeutics Appoints John Cox As CEO To Succeed Joshua Brumm markets.businessinsider.com - March 25 at 9:25 AM
	Dyne Therapeutics CEO Joshua Brumm to Exit For Investing Career marketwatch.com - March 25 at 9:25 AM
	Dyne Therapeutics Announces CEO Transition globenewswire.com - March 25 at 7:30 AM
	Dyne Therapeutics (NASDAQ: DYN) fool.com - March 20 at 4:45 PM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Short Interest Update marketbeat.com - March 19 at 9:20 PM
	Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 4.4% marketbeat.com - March 18 at 11:56 AM
	DYN Apr 2024 30.000 put finance.yahoo.com - March 18 at 12:21 AM
	Walleye Capital LLC Takes $2.51 Million Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) marketbeat.com - March 17 at 4:20 AM
	DYN Apr 2024 22.500 call finance.yahoo.com - March 16 at 6:15 PM
	DYN Apr 2024 30.000 call ca.finance.yahoo.com - March 16 at 8:14 AM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Sold by Vida Ventures Advisors LLC marketbeat.com - March 14 at 6:40 PM
	Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge markets.businessinsider.com - March 14 at 4:08 PM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) COO Sells $58,904.40 in Stock insidertrades.com - March 14 at 9:52 AM
	Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days globenewswire.com - March 13 at 7:30 AM
	Wildon Farwell Sells 1,585 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock insidertrades.com - March 13 at 7:20 AM
	Susanna Gatti High Sells 2,292 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock marketbeat.com - March 13 at 7:19 AM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) SVP Richard William Scalzo Sells 2,672 Shares insidertrades.com - March 13 at 7:01 AM
	Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) COO Sells 1,591 Shares of Stock insidertrades.com - March 12 at 5:23 AM
	Susanna Gatti High Sells 1,591 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock marketbeat.com - March 11 at 10:33 PM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Sold by Fmr LLC marketbeat.com - March 9 at 4:21 AM
	Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know markets.businessinsider.com - March 8 at 1:25 PM
	HC Wainwright Comments on Dyne Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:DYN) marketbeat.com - March 8 at 7:21 AM
	Dyne Therapeutics stock target raised to $41 by Stifel investing.com - March 7 at 6:29 PM
	Dyne Therapeutics stock target raised to $47 on promising data investing.com - March 7 at 6:29 PM
	Dyne Therapeutics Inc (DYN) Reports Encouraging Clinical Data and Financial Growth for Q4 and ... finance.yahoo.com - March 7 at 1:29 PM
	Dyne Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.83) Per Share, HC Wainwright Forecasts (NASDAQ:DYN) marketbeat.com - March 7 at 6:40 AM
	Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know markets.businessinsider.com - March 6 at 6:25 PM
	Dyne Therapeutics: Strong Buy on Promising Clinical Data and Superior Therapeutic Platform markets.businessinsider.com - March 6 at 4:17 PM
	Buy Rating Affirmed for Dyne Therapeutics Amidst Promising Drug Data and Strategic Market Positioning markets.businessinsider.com - March 6 at 4:17 PM
	Dyne Therapeutics (NASDAQ:DYN) Earns Buy Rating from HC Wainwright marketbeat.com - March 6 at 1:39 PM
	Stifel Nicolaus Raises Dyne Therapeutics (NASDAQ:DYN) Price Target to $41.00 marketbeat.com - March 6 at 10:40 AM
	Dyne Therapeutics (NASDAQ:DYN) Announces Quarterly Earnings Results marketbeat.com - March 6 at 9:45 AM
	Dyne: H2 2024 Muscle Disease Data Could Boost Value seekingalpha.com - March 5 at 2:48 PM
	Dyne Therapeutics, Inc.: Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights finanznachrichten.de - March 5 at 2:08 PM
	DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q4 2023 investorplace.com - March 5 at 12:39 PM
	Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Rating of "Buy" from Brokerages marketbeat.com - March 5 at 10:05 AM

Get Dyne Therapeutics News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

DYN Media Mentions By Week

DYN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DYN
News Sentiment
▼
1.93

0.52
▲
Average
Medical
News Sentiment

DYN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DYN Articles
This Week
▼
2

3
▲
DYN Articles
Average Week

Get Dyne Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:DYN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dyne Therapeutics (DYN) News Today

DYN Media Mentions By Week

DYN Media Sentiment

DYN News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info